The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALECTOR INC | COM | 014442107 | 20,255 | 980,894 | SH | SOLE | 980,894 | 0 | 0 | ||
| FIRST FINL BANCORP OH | COM | 320209109 | 4,232 | 173,576 | SH | SOLE | 173,576 | 0 | 0 | ||
| FOGHORN THERAPEUTICS INC | COM | 344174107 | 28,845 | 1,261,261 | SH | SOLE | 1,261,261 | 0 | 0 | ||
| MARQETA INC | CLASS A COM | 57142B104 | 4,254 | 247,752 | SH | SOLE | 247,752 | 0 | 0 | ||
| NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 13,224 | 746,674 | SH | SOLE | 746,674 | 0 | 0 | ||
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | 10,989 | 747,550 | SH | SOLE | 747,550 | 0 | 0 | ||
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | 53,983 | 2,336,909 | SH | SOLE | 2,336,909 | 0 | 0 | ||
| RAPT THERAPEUTICS INC | COM | 75382E109 | 15,900 | 432,900 | SH | SOLE | 432,900 | 0 | 0 | ||
| SURROZEN INC | COM | 86889P109 | 5,171 | 802,964 | SH | SOLE | 802,964 | 0 | 0 | ||
| TENAYA THERAPEUTICS INC | COM | 87990A106 | 17,353 | 915,705 | SH | SOLE | 915,705 | 0 | 0 | ||
| VIR BIOTECHNOLOGY INC | COM | 92764N102 | 1,686 | 40,257 | SH | SOLE | 40,257 | 0 | 0 | ||